LEO PHARMA AT A GLANCE
1908 in Denmark
Founded and headquartered in Denmark, currently employing 6,000 professionals across 61 countries.
+130 countries
Supplying treatments to people with medical needs in more than 130 countries around the world.
125 million lives
Striving to positively impact the lives of 125 million people through medical dermatology by 2025.
LEO PHARMA AT A GLANCE
BALLERUP, Denmark, December 11, 2019 – LEO Pharma A/S, a global leader in medical dermatology, today announced that tralokinumab – an investigational, fully human monoclonal antibody that specifically neutralizes the interleukin-13 (IL-13) cytokine –
Read our annual report






